MoneyWorks4Me

The Revenue for the quarter ended  March 2025 of Rs. 410.47 millions grew by 5.68 % from Rs. 388.42 millions.A humble growth in net profit of 8.28% reported in the quarter ended March 2025 to Rs. 85.36  millions from Rs. 78.83 millions.The company reported a good operating profit of 127.37 millions compared to 110.42 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 410.47 388.42 5.68 1516.92 1419.66 6.85 1516.92 1419.66 6.85
Other Income 18.80 11.89 58.12 67.21 46.67 44.01 67.21 46.67 44.01
PBIDT 127.37 110.42 15.35 471.13 377.85 24.69 471.13 377.85 24.69
Interest 1.11 0.58 91.38 4.53 2.71 67.16 4.53 2.71 67.16
PBDT 126.26 109.84 14.95 466.60 375.14 24.38 466.60 375.14 24.38
Depreciation 7.91 6.18 27.99 27.28 23.40 16.58 27.28 23.40 16.58
PBT 118.35 103.66 14.17 439.32 351.74 24.90 439.32 351.74 24.90
TAX 32.99 24.83 32.86 118.72 91.98 29.07 118.72 91.98 29.07
Deferred Tax -2.79 -1.68 66.07 -2.06 -5.21 -60.46 -2.06 -5.21 -60.46
PAT 85.36 78.83 8.28 320.60 259.76 23.42 320.60 259.76 23.42
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 31.03 28.43 9.15 31.06 26.62 16.69 31.06 26.62 16.69
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..